| 摘要 |
Amylin or amylin-NH2 or CGRP or a functional peptide fragment of amylin or amylin-NH2 or CGRP, or a conservative variant of the amylin or amylin-NH2 or CGRP or fragment, is provided as well as a soluble amylin or amylin-amide or active subfragment thereof or a lyophilized product for use in the treatment of diabetes mellitus or hypoglycaemia. Methods for preparation thereof are provided. |
